WA
TEVA icon

WFG Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

WFG Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$989K Buy
29,784
+28,701
+2,650% +$888K 0.22% 110
2017
Q1 		$35K Sell
1,083
-868
-44% -$29.6K 0.01% 759
2016
Q4 		$71K Sell
1,951
-143
-7% -$5.71K 0.02% 630
2016
Q3 		$96K Buy
2,094
+14
+0.7% +$730 0.02% 532
2016
Q2 		$104K Buy
2,080
+256
+14% +$13.6K 0.03% 486
2016
Q1 		$98K Buy
1,824
+6
+0.3% +$352 0.03% 474
2015
Q4 		$119K Sell
1,818
-94
-5% -$5.81K 0.04% 428
2015
Q3 		$108K Sell
1,912
-252
-12% -$16.3K 0.03% 446
2015
Q2 		$128K Buy
2,164
+12
+0.6% +$740 0.04% 466
2015
Q1 		$134K Sell
2,152
-1,592
-43% -$92.6K 0.04% 447
2014
Q4 		$215K Buy
3,744
+76
+2% +$4.23K 0.04% 407
2014
Q3 		$197K Sell
3,668
-80
-2% -$4.24K 0.04% 455
2014
Q2 		$196K Buy
3,748
+339
+10% +$17.3K 0.04% 451
2014
Q1 		$180K Sell
3,409
-1,625
-32% -$75.1K 0.04% 461
2013
Q4 		$202K Buy
5,034
+809
+19% +$31.9K 0.03% 516
2013
Q3 		$160K Buy
4,225
+499
+13% +$19.5K 0.02% 553
2013
Q2 		$146K Buy
+3,726
New +$145K 0.02% 548

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WFG Advisors's TEVA Position: Q2 2017 in Review

WFG Advisors increased its Teva Pharmaceuticals (TEVA) stake by 2,650% in Q2 2017, buying an estimated $888K and bringing the position to 29,784 shares worth $989K. The position accounts for 0.22% of the portfolio, ranked #110.

WFG Advisors first reported a position in TEVA in Q2 2013 and has held it in 17 quarters since. 648 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • WFG Advisors held 29,784 shares of Teva Pharmaceuticals worth $989K as of Q2 2017.
  • WFG Advisors bought 28,701 Teva Pharmaceuticals shares in Q2 2017, an estimated $888K.
  • Teva Pharmaceuticals made up 0.22% of WFG Advisors's portfolio in Q2 2017, its #110 holding.
  • WFG Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 17 quarters since.
  • 648 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.